Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 1/20 | 0.42 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.37 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.37 |
| ▸ | LTA4H | P09960 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 14/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 9/20 | 0.36 |
| ▸ | TSHR | P16473 | 8/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 7/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 7/20 | 0.36 |
| ▸ | LMNA | P02545 | 3/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | HBB | P68871 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | MKNK2 | Q9HBH9 | 1/20 | 0.35 |
| ▸ | USP2 | O75604 | 5/20 | 0.34 |
| ▸ | CLK4 | Q9HAZ1 | 3/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2120550 | 0.77 | FDPS (0.45) | FDPSHDAC1HDAC6LTA4HCYP1A2 | |
| SCHEMBL28340215 | 0.76 | FDPS (0.44) | FDPSHDAC1HDAC6LTA4HCYP1A2 | |
| SCHEMBL28779724 | 0.74 | FDPS (0.42) | FDPSHDAC1HDAC6LTA4HCYP1A2 | |
| SCHEMBL10664500 | 0.74 | FDPS (0.46) | FDPSHDAC1HDAC6LTA4HCYP1A2 | |
| SCHEMBL28763050 | 0.74 | FDPS (0.46) | FDPSHDAC1HDAC6LTA4HCYP1A2 | |
| SCHEMBL357004 | 0.74 | FDPS (0.42) | FDPSHDAC1HDAC6LTA4HCYP1A2 | |
| SCHEMBL5633 | 0.74 | FDPS (0.42) | FDPSHDAC1HDAC6LTA4HCYP1A2 | |
| SCHEMBL840562 | 0.74 | FDPS (0.46) | FDPSHDAC1HDAC6LTA4HCYP1A2 | |
| SCHEMBL5578780 | 0.74 | FDPS (0.42) | FDPSHDAC1HDAC6LTA4HCYP1A2 | |
| SCHEMBL30341176 | 0.74 | GRM5 (0.46) | FDPSHDAC1HDAC6LTA4HCYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-100490818-C | Methods for treating hepatitis delta virus infection with beta-L-2' deoxy-uncleosides | NOVARTIS AG (CH) | 2009-05-27 | — | — | CN | claimed |
| WO-2023109870-A1 | PYRAZOLOPYRIMIDINE COMPOUND AND USE THEREOF | 上海壹迪生物技术有限公司 | 2023-06-22 | — | — | WO | disclosed |
| US-10915023-B2 | Nitrogen heterocycle-containing monolayers on metal oxides for binding biopolymers | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2021-02-09 | — | — | US | disclosed |
| US-20190137879-A1 | NITROGEN HETEROCYCLE-CONTAINING MONOLAYERS ON METAL OXIDES FOR BINDING BIOPOLYMERS | INTERNATIONAL BUSINESS MACHINES CORPORATION | 2019-05-09 | — | — | US | disclosed |
| CN-108524505-A | Method and composition for cell Proliferation associated disease | 安吉奥斯医药品有限公司 | 2018-09-14 | — | — | CN | disclosed |
| CN-102985557-B | Methods and compositions for cell proliferation-related disorders | 安吉奥斯医药品有限公司 | 2018-06-15 | — | — | CN | disclosed |
| CN-103638522-A | Methods of increasing lymphatic function | GEN HOSPITAL CORP | 2014-03-19 | — | — | CN | disclosed |
| CN-101120947-B | Beta-l-2'-deoxy-nucleosides for the treatment of hepatitis b | IDENIX PHARMACEUTICALS INC (US) | 2010-11-24 | — | — | CN | disclosed |
| CN-1911237-B | Beta - l-2'-deoxy-nucleosides for the treatment of hepatitis b | IDENIX PHARMACEUTICALS INC (US) | 2010-09-15 | — | — | CN | disclosed |
| CN-101148448-B | Method for preparing N2-quinoline substituted purine derivative | ZHEJIANG MEDICAL CO LTD XINCHANG PHARMACEUTICAL PLANT | 2010-08-04 | — | — | CN | disclosed |
| CN-1911237-A | Beta - l-2'-deoxy-nucleosides for the treatment of hepatitis b | IDENIX CAYMAN LTD (KY) | 2007-02-14 | — | — | CN | disclosed |
| CN-1268345-C | Method of treating hepatitis delta viral infection | UNIV GEORGETOWN (US) | 2006-08-09 | — | — | CN | disclosed |
| CN-1257912-C | beta-L-2' -deoxy-nucleosides for the treatment of hepatitis B | IDENEX CAYMAN LTD (GB) | 2006-05-31 | — | — | CN | disclosed |
| CN-1606983-A | beta-L-2' -deoxy-nucleosides for the treatment of hepatitis B | IDENIX CAYMAN LTD (KY) | 2005-04-20 | — | — | CN | disclosed |
| CN-1478483-A | Beta-L-2'-dioxidition-nucleoside for treating hepatitis B | ŵ�������ҩ����˾ | 2004-03-03 | — | — | CN | disclosed |
| CN-1444483-A | Methods of treating hepatitis delta virus infection with beta-L-2' -deoxynucleosides | EDENNICKS CAYMAN CO LTD (KY) | 2003-09-24 | — | — | CN | disclosed |
| CN-1431907-A | Methods of treating hepatitis delta virus infection | UNIV GEORGETOWN (US) | 2003-07-23 | — | — | CN | disclosed |
| CN-1320128-A | beta-L-2' -deoxy-nucleosides for the treatment of hepatitis B | NORIVIO PHARMACEUTICALS LTD (FR) | 2001-10-31 | — | — | CN | disclosed |
| JP-2001072680-A | NEW METHOD FOR PRODUCING PURINE IODIDE DERIVATIVE | EISAI CO LTD | 2001-03-21 | — | — | JP | disclosed |
| JP-2001072680-A | NEW METHOD FOR PRODUCING PURINE IODIDE DERIVATIVE | EISAI CO LTD | 2001-03-21 | — | — | JP | disclosed |